Neuropathic pain

Hospital Medicine

Volumn 61, Issue 11, 2000, Pages 760-766

  Smith, T E ^a   Chong, M S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

BEHAVIOR THERAPY; CLASSIFICATION; HUMAN; NEUROLOGIC DISEASE; PAIN; REVIEW; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME;

ANALGESICS; BEHAVIOR THERAPY; HUMANS; NERVOUS SYSTEM DISEASES; PAIN; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 0034326880     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2000.61.11.1459     Document Type: Article

References (19)

1. Backonja M, Beydoun A, Edwards KR et al (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomised controlled trial. JAMA 280: 1831-6
2. Besson JM (1999) The neurobiology of pain. Lancer 353: 1610-15
3. Bowsher D (1991) Neurogenic pain syndromes and their management. Br Med Bull 47: 644-66
4. Dellemijn PLI. Vanneste JAL (1997) Randomised double-blind active-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 349: 753-8
5. Eglen RM, Hunter JC, Dray A (1999) Ions in the fire recent ion-channel research and approaches to pain therapy. Trends Pharmacolog Sci 20: 337-42
6. Fields HL, Rowbotham M, Baron R (1998) Postherpatic neuralgia irritable nociceptors and deafferentation. Neurobiol Disease 5: 209-27
7. Kalso E, Tramer MR, Moore RA. McQuay HJ (1998) Systemic local anaesthetic type drugs in chronic pain a qualitative systematic review. Eur J Pain 2: 3-14
8. Merskey H, Bogduk N, eds (1994) Classification of Chronic Pain. 2nd edn. IASP Press. Seattle
9. McQuay HJ, Moore RA (1998) An Evidence Based Resource for Pain Relief. Oxford University Press, Oxford
10. McQuay H, Tramer M, Nye BA, Carroll D, Wiffen P, Moore A (1995) Anticonvulsant drugs for the management of pain a systematic review. Br Med J 311: 1047-52
11. Ochoa JL (1999) Truths, errors and lies around 'reflex sympathetic dystrophy' and 'complex regional pain syndrome'. J Neuml 246: 875-9
12. Oskarsson P, Lins PE, Ljunggren JG, Mexilitene Study Group (1997) Efficacy and safety of mexilitene in the treatment of painful diabetic neuropathy. Diabetes Care 20: 1594-7
13. Parry GJ (1999) Management of diabetic neuropathy. Am J Med 107 (2B): 27S-33S
14. Ramer MS, Thompson SWN, McMahon SB (1999) Causes and consequences of sympathetic basket formation in the dorsal root ganglia. Pain Suppl 6: SI 11-S120
15. Rowbotham M, Harden N, Stacey B, Berstein P, MagnusMiller L (1998) Gabapentin for the treatment of postherpatic neuralgia a randomised controlled trial. JAMA 280: 1837-42
16. Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain an update and effect related to mechanism of action. Pain 83: 389-400
17. Wells JC, Miles JB (1991) Pain clinics and and pain clinic treatments. Br Med Bull 47: 762-85
18. Woolf CJ, Decosterd 1 (1999) Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain Suppl 5: S141-S147
19. Yaksh TL (1999) Spinal systems and pain processing development of novel analgesic drugs with mechanistically defined models, Trends Pharmacolog Sci 20: 329-37